Tonic Life Communications wins global Cardiorentis brief

Biopharmaceutical firm Cardiorentis has brought in an agency to lead its global PR strategy, as it attempts to gain ground in the cardiology drug market.

Risk: Heart failure affects one in 100 people in the UK
Risk: Heart failure affects one in 100 people in the UK

Switzerland-based Cardiorentis, which was founded in 2010 to focus on treatments for cardiovascular diseases, has called in Tonic Life Communications for the global brief.

The agency will provide PR and medical comms support to the brand, which currently has no dedicated in-house comms team.

Tonic’s mandate also stretches to medical congress support, data dissemination and corporate profiling.

A particular focus will be on Cardiorentis’ flagship drug Ularitide, which is entering into phase 3 of a clinical trial for treatment of acute heart failure. The company may also investigate use of the drug for treatment of long-term heart conditions.

Cardiorentis is headed by Merck Serono’s former CEO Elmar Schnee and claims to be one of the first start-up companies to invest in a phase 3 clinical trial programme – a process usually carried out by larger pharma companies.

Associate director Helen Swift will lead the retained account, which runs from now until the end of 2013, reporting directly to Schnee.

Heart failure affects at least one in 100 people in the UK and is responsible for one in 20 admissions to hospital, while 30–40 per cent of patients diagnosed with heart failure die within a year.

Tonic CEO Scott Clark said: ‘Cardiorentis has a refreshing new approach to drug development which it combines with entrepreneurial spirit, something that reflects Tonic’s own values.’

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.